Purchases and Sales Made in Q1 2025 in Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO) during Q1 2025. The information is specifically focused on institutions that hold shares of BridgeBio Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Exome Asset Management LLC
New York, NY |
SELL
|
- |
-81.2K- 32.92% |
$2.28M - $3.05M
|
165K
$7.57M
|
|
|
May 15, 2025
Q1 2025
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-89.3K- 39.95% |
$2.51M - $3.36M
|
134K
$6.14M
|
|
|
May 15, 2025
Q1 2025
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-110K- 3.94% |
$3.1M - $4.14M
|
2.68M
$123M
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-124K- 41.5% |
$3.49M - $4.67M
|
175K
$8.01M
|
|
|
May 15, 2025
Q1 2025
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-125K- 57.89% |
$3.51M - $4.69M
|
90.8K
$4.16M
|
|
|
May 14, 2025
Q1 2025
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-125K- 6.34% |
$3.52M - $4.71M
|
1.85M
$84.7M
|
|
|
May 12, 2025
Q1 2025
|
Citigroup Inc
|
SELL
|
- |
-137K- 8.92% |
$3.86M - $5.16M
|
1.4M
$64.1M
|
|
|
May 16, 2025
Q1 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-165K- 6.91% |
$4.64M - $6.2M
|
2.22M
$102M
|
|
|
May 15, 2025
Q1 2025
|
Cutter Capital Management, LP
New York, NY |
SELL
|
- |
-170K- 30.28% |
$4.77M - $6.38M
|
391K
$17.9M
|
|
|
May 09, 2025
Q1 2025
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-178K- 1.18% |
$5M - $6.68M
|
14.9M
$682M
|
|
|
May 14, 2025
Q1 2025
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-220K- 94.49% |
$6.19M - $8.28M
|
12.8K
$588K
|
|
|
May 15, 2025
Q1 2025
|
Frontier Capital Management CO LLC
|
SELL
|
- |
-307K- 28.49% |
$8.62M - $11.5M
|
769K
$35.2M
|
|
|
May 15, 2025
Q1 2025
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-339K- 49.97% |
$9.54M - $12.8M
|
340K
$15.5M
|
|
|
May 15, 2025
Q1 2025
|
Prosight Management, LP
Dallas, TX |
SELL
|
- |
-385K- 38.69% |
$10.8M - $14.5M
|
610K
$27.9M
|
|
|
May 15, 2025
Q1 2025
|
Aristeia Capital LLC
Greenwich, CT |
SELL
|
- |
-388K- 94.28% |
$10.9M - $14.6M
|
23.6K
$1.08M
|
|
|
May 15, 2025
Q1 2025
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-406K- 49.05% |
$11.4M - $15.3M
|
422K
$19.3M
|
|
|
May 15, 2025
Q1 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-433K- 7.0% |
$12.2M - $16.3M
|
5.75M
$263M
|
|
|
May 14, 2025
Q1 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-485K- 39.58% |
$13.6M - $18.2M
|
740K
$33.9M
|
|
|
May 15, 2025
Q1 2025
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-539K- 59.5% |
$15.1M - $20.2M
|
367K
$16.8M
|
|
|
May 15, 2025
Q1 2025
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-586K- 26.49% |
$16.5M - $22M
|
1.63M
$74.4M
|
|
|
May 15, 2025
Q1 2025
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-763K- 20.39% |
$21.4M - $28.7M
|
2.98M
$136M
|
|
|
May 15, 2025
Q1 2025
|
Viking Global Investors LP
|
SELL
|
- |
-3.07M- 12.2% |
$86.2M - $115M
|
22.1M
$1.01B
|
|
|
May 15, 2025
Q1 2025
|
Kohlberg Kravis Roberts & Co. L.P.
New York, NY |
SELL
|
- |
-6M- 23.75% |
$169M - $226M
|
19.3M
$882M
|